Limatoc, Ailene C.
HRN: 26-30-36 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/29/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/29/2024
12/06/2024
IVT
500mg
BID
H Pylori
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes